News & Events

News Releases


Year: 2008 |2007 |2006 |2005 | 2004 | 2003

Dec 21, 2007

Aspreva Receives Investment Canada Approval for Acquisition by Galenica

Dec 18, 2007

Aspreva Receives Final Court Approval for Acquisition by Galenica

Dec 17, 2007

Aspreva Obtains Shareholder Approval for Acquisition by Galenica

Nov 23, 2007

Aspreva Sends Materials for Special Meeting Held December 17

Oct 31, 2007

Aspreva Announces Results for Third Quarter 2007

Oct 17, 2007

Aspreva to be Acquired by Galenica for US$915 Million

Oct 16, 2007

Aspreva Announces Preliminary Revenues for Third Quarter 2007

Oct 15, 2007

Aspreva to Announce 2007 Third Quarter Results on October 31st

Sep 10, 2007

Aspreva Provides Update on Lupus Nephritis Development Program

Aug 28, 2007

Aspreva and Roche Update the CellCept Agreement

Jul 31, 2007

Aspreva Announces Results for Second Quarter 2007

Jul 25, 2007

Aspreva Announces Restructuring Designed to Drive Long-Term Growth

Jul 16, 2007

Aspreva Announces Preliminary Revenues for Second Quarter 2007

Jul 13, 2007

Aspreva to Announce 2007 Second Quarter Results on August 1st

Jul 11, 2007

J. William Freytag, Ph.D. Appointed Chairman and Chief Executive Officer

Jun 27, 2007

Aspreva and Roche Announce Preliminary Results for Phase III Study Evaluating CellCept in LN

Jun 06, 2007

Aspreva to Present at the Sixth Annual Needham Biotechnology and Medical Technology Conference in New York

Jun 06, 2007

Aspreva Announces Fast-Track Designation Granted by the FDA for CellCept in Lupus Nephritis

May 24, 2007

Aspreva to Present at the Bank of America 2007 Health Care Conference in Las Vegas

May 22, 2007

Aspreva Completes Expanded Patient Enrollment in Phase III Clinical Trial for CellCept in Pemphigus Vulgaris

May 02, 2007

Aspreva Reports Results for First Quarter 2007 and Announces Leadership Transition of Founding CEO Richard Glickman

Apr 18, 2007

Aspreva Announces Preliminary Revenues for First Quarter 2007

Apr 16, 2007

Aspreva to Release 2007 First Quarter Results on May 2nd

Apr 04, 2007

Aspreva Pharmaceuticals to Present at the CIBC World Markets Biotechnology and Specialty Pharmaceuticals Conference

Feb 07, 2007

Aspreva Reports 2006 Fourth Quarter and Year End Results and Provides 2007 Revenue Guidance

Feb 01, 2007

Aspreva to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Devices Conference in New York

Jan 11, 2007

Aspreva Announces Preliminary Revenues for Fourth Quarter and Fiscal Year 2006

Jan 09, 2007

Aspreva to Release 2006 Fourth Quarter and Full Year Results on February 7th